DCGI office lashes to FDC(Fixed Dose Composition) Pharma companies who has not submitted the phase IV study protocol to be reviewed by Expert Committee. It is good to see that DCGI office is becoming stringent where they were suppose to be stern and making the companies accountable for their actions.

noticesept1

DCGI Office Lashes to FDC Pharma companies

Leave a Reply

Your email address will not be published. Required fields are marked *

Visit Us On TwitterVisit Us On Google PlusVisit Us On LinkedinVisit Us On Facebook